Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

357 trials

NCT06863350
Recruiting
Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT-PFO Trial）
Not applicable · China · 1 site
Registry update: 11 Mar 2025
NCT07413211
Recruiting
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
Not applicable · United States · 1 site
Registry update: 17 Feb 2026
NCT07668856
Recruiting
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
Phase 3 · Netherlands · 1 site
Registry update: 25 Jun 2026
NCT06736002
Recruiting
Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study
Not applicable · Taiwan · 1 site
Registry update: 13 Apr 2026
NCT06883981
Recruiting
Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings
Not applicable · United States · 1 site
Registry update: 8 Apr 2025
NCT06814665
Recruiting
Improving Diagnostics and Care After First Seizure
Not applicable · Norway · 1 site
Registry update: 7 Feb 2025
2024-520427-86-00
Recruiting
Phase I, open-label clinical trial to evaluate the safety and clinical response of repeated-dose intra-arterial infusion of autologous mesenchymal cells in children and adolescents with refractory epilepsies.
Phase 1 · Spain · 1 site
Registry update: 24 Jan 2025
2023-507843-12-01
Recruiting
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach
Phase 3 · Netherlands · 5 sites
Registry update: 31 Dec 2025
NCT05794295
Recruiting
Sleep Architecture & Cognition in Focal Epilepsy
Not applicable · United States · 1 site
Registry update: 7 Aug 2026
NCT06667232
Recruiting
Evaluating Modulation Effects of Burst Stimulation Patterns Using SEEG
Not applicable · China · 1 site
Registry update: 22 Jan 2025
NCT06908356
Recruiting
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · Australia, Spain, United States · 11 sites
Registry update: 3 Apr 2025
NCT06205160
Recruiting
Evaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery. ( EpiGrid )
Not applicable · Netherlands · 1 site
Registry update: 10 Dec 2025
NCT06798896
Recruiting
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Phase 2 · Australia, Bulgaria, Hungary, Poland, United States · 63 sites
Registry update: 1 Oct 2026
NCT06719791
Recruiting
Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
Early phase 1 · China · 1 site
Registry update: 31 Dec 2024
NCT06922175
Recruiting
REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
Not applicable · Switzerland, Germany, Spain, United Kingdom, Netherlands · 10 sites
Registry update: 2 Oct 2025
NCT06716801
Recruiting
Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
Not applicable · France · 1 site
Registry update: 19 Sept 2025
NCT06695767
Recruiting
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
Not applicable · United States · 2 sites
Registry update: 9 Jan 2025
NCT06334952
Recruiting
Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic
Not applicable · France · 7 sites
Registry update: 19 Dec 2025
NCT06401538
Recruiting
BMB-101 in Absence Epilepsy and DEE
Phase 2 · Australia · 5 sites
Registry update: 12 Aug 2025
NCT06708143
Recruiting
Temporal Interference for Drug Resistant Epilepsy
Not applicable · China · 1 site
Registry update: 17 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.